|
Oct 9
|
XORTX Initiates Precision Medicine Program
|
|
Feb 15
|
XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units
|
|
Jan 15
|
XORTX Announces $2 Million Public Offering
|
|
Jan 2
|
XORTX Welcomes New Member to the Board of Directors
|
|
Nov 30
|
XORTX Announces US ATM Offering
|
|
Nov 29
|
XORTX Meets Nasdaq Continued Listing Requirements
|
|
Oct 27
|
XORTX Announces Results of Special Meeting of Shareholders
|
|
Oct 25
|
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
|
|
Oct 25
|
XORTX Announces Rescheduling of Special Meeting of Shareholders
|
|
Aug 4
|
XORTX Appoints Chief Financial Officer
|
|
Jun 24
|
XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company’s Upcoming Annual and Special Meeting of Shareholders
|